Displaying drugs 13926 - 13950 of 14686 in total
Pixofisiran
Investigational
Lixadesiran
Investigational
Hepcortespenlisimut-L
Investigational
Leukocyte interleukin
Investigational
Prexigebersen
Investigational
MEM136
Investigational
CRS-207
Investigational
Listeria monocytogenes
Investigational
RAD 502
Investigational
Imvotamab
Investigational
IMGN632
Investigational
ICG-136
ICG-136 is a compound chimeric antigen receptor (cCAR) T-cell therapy developed by iCell Gene Therapeutics. It was investigated for the treatment of acute myeloid leukemia.
Investigational
LSTA1
Investigational
AIC100
Investigational
WT-1 427 long
Investigational
WT-1 331 long
Investigational
TALL-104
Investigational
Obecabtagene autoleucel
Obecabtagene autoleucel is an investigational autologous CD19 CAR T cell therapy.
Investigational
Gavocabtagene autoleucel
Gavocabtagene autoleucel is a novel cell therapy consisting of autologous genetically engineered T cells expressing a single-domain antibody that recognizes human Mesothelin, fused to the CD3-epsilon subunit which, upon expression, is incorporated into the endogenous T cell receptor (TCR) complex.
Investigational
TBX-3400
TBX-3400 is an investigational cell-based immunotherapy consisting of autologous peripheral blood mononuclear cells (PBMCs) treated ex vivo with TBX-4000, which is a recombinant TAT-MYC fusion protein.[L44281,L44286]
Investigational
Human Recombinant Bone Morphogenetic Protein 4
Investigational
Ferritarg P
Investigational
Trastuzumab vedotin
Investigational
Displaying drugs 13926 - 13950 of 14686 in total